Hydrexia Facilitates SEDCE with Historical Regional Maritime Shipment of Solid-state Hydrogen
KUCHING, Malaysia, Oct. 23, 2025 /PRNewswire/ -- Hydrexia Holding Limited ("Hydrexia"), a leading hydrogen technology solution provider, announced today that the company is facilitating the first-ever maritime shipment of hydrogen roadshow from...
Callio Therapeutics Launches with US$187 Million Series A to Advance Multi-Payload Antibody-Drug Conjugate Platform Through Clinical Proof-of-Concept
Frazier Life Sciences launches Callio Therapeutics based on multi-payload antibody-drug conjugate technology and programs exclusively in-licensed from Singapore-based Hummingbird Bioscience Financing led by Frazier Life Sciences with significant...